Hsbc Holdings PLC Biogen Inc. Transaction History

Hsbc Holdings PLC

$160 Billion
Q2 2024

A detailed history of Hsbc Holdings PLC transactions in Biogen Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 378,437 shares of BIIB stock, worth $65.8 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

378,437

Previous 398,842 5.12%

Holding current value

$65.8 Million

Previous $86 Million 2.01%

% of portfolio

0.05%

Previous 0.06%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$190.52 - $236.72 $3.89 Million - $4.83 Million	-20,405 Reduced 5.12%	378,437 $87.7 Million
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $15.5 Million - $19.6 Million	73,234 Added 22.49%	398,842 $86 Million
Q4 2023 Feb 12, 2024	BUY	$222.59 - $267.94 $11.8 Million - $14.2 Million	52,974 Added 19.43%	325,608 $84.3 Million
Q3 2023 Nov 13, 2023	SELL	$253.3 - $285.89 $2.75 Million - $3.11 Million	-10,875 Reduced 3.84%	272,634 $70.1 Million
Q2 2023 Aug 11, 2023	BUY	$275.25 - $318.06 $9.2 Million - $10.6 Million	33,429 Added 13.37%	283,509 $80.8 Million
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $8.17 Million - $9.31 Million	-31,858 Reduced 11.3%	250,080 $69.5 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $28.2 Million - $34.3 Million	111,755 Added 65.67%	281,938 $78.1 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $7.04 Million - $9.7 Million	-36,149 Reduced 17.52%	170,183 $45.4 Million
Q2 2022 Aug 11, 2022	BUY	$187.54 - $223.02 $7.51 Million - $8.94 Million	40,071 Added 24.1%	206,332 $42.4 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $1.94 Million - $2.45 Million	10,034 Added 6.42%	166,261 $35.1 Million
Q4 2021 Feb 11, 2022	BUY	$223.92 - $287.77 $89,568 - $115,108	400 Added 0.26%	156,227 $37.5 Million
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $5.16 Million - $6.73 Million	-18,240 Reduced 10.48%	155,827 $44.3 Million
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $23 Million - $36.9 Million	-88,967 Reduced 33.82%	174,067 $60.3 Million
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $1.68 Million - $1.97 Million	-6,908 Reduced 2.56%	263,034 $73.6 Million
Q4 2020 Feb 25, 2021	BUY	$236.26 - $355.63 $19.1 Million - $28.7 Million	80,718 Added 42.66%	269,942 $66.1 Million
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $10 Million - $15.1 Million	-42,336 Reduced 18.28%	189,224 $46.3 Million
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $10.5 Million - $12.1 Million	-39,559 Reduced 14.59%	231,560 $65.7 Million
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $20.2 Million - $26.7 Million	77,992 Added 40.38%	271,119 $72.5 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $40.4 Million - $51.2 Million	-150,229 Reduced 43.75%	193,127 $61 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $17.2 Million - $23.7 Million	78,036 Added 29.41%	343,356 $101 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $444,447 - $498,490	-2,044 Reduced 0.76%	265,320 $61.8 Million
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $9.73 Million - $10.7 Million	-44,384 Reduced 14.24%	267,364 $62.5 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $19.9 Million - $31.2 Million	91,994 Added 41.86%	311,748 $73.7 Million
Q4 2018 Feb 13, 2019	SELL	$278.5 - $352.75 $1.07 Million - $1.36 Million	-3,856 Reduced 1.72%	219,754 $66.1 Million
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $7.75 Million - $10.1 Million	26,419 Added 13.4%	223,610 $79 Million
Q2 2018 Aug 10, 2018	SELL	$257.52 - $306.91 $43 Million - $51.2 Million	-166,909 Reduced 45.84%	197,191 $57.2 Million
Q1 2018 May 11, 2018	BUY	$260.13 - $367.91 $9.14 Million - $12.9 Million	35,143 Added 10.68%	364,100 $99.7 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $5.16 Million - $5.78 Million	-16,783 Reduced 4.85%	328,957 $105 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $12 Million - $14.1 Million	42,816 Added 14.13%	345,740 $108 Million
Q2 2017 Aug 14, 2017	BUY	N/A	302,924	302,924 $82.2 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Biogen Inc. Transaction History